• Reena Gogia Rastogi, Eric Vance Hastriter, Rachel L Evans, Frederick Bassal, Carolyn Hickman, Kavitha T Karnik, Robert Little, and Kara Stuart Lewis.
• Department of Neurology, Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, USA. rrastogi@phoenixchildrens.com.
• Curr Pain Headache Rep. 2023 Oct 1; 27 (10): 521529521-529.

Purpose Of ReviewHeadaches are common in children and adolescents. Treatments for debilitating migraine are often not FDA approved or lack evidence of efficacy for children. This narrative review looks at the evidence for acute and preventative pharmacologic and non-pharmacologic treatment of pediatric migraine, as well as reviewing any recent or ongoing clinical trials.Recent FindingsStudies have been published on pharmacological treatments for headache, as well as non-pharmacological treatments. Recent findings in pediatric migraine using onabotulinumtoxinA, calcitonin gene related peptide antagonists, interventional procedures, and devices are reviewed. Pharmacologic as well as non-pharmacologic approaches for the prevention and treatment of migraine show safety and efficacy data that is promising. These treatments should be incorporated in a multi-modal approach to the management of pediatric migraine. Continued studies, prospective and randomized, are needed to further assess these newer treatments for migraine in the pediatric setting.© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

14 keywords...

hide…